Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Proproliferative and antiapoptotic action of exogenously introduced YAP in pancreatic β cells
Ting Yuan, Sahar Rafizadeh, Zahra Azizi, Blaz Lupse, Kanaka Durga Devi Gorrepati, Sushil Awal, Jose Oberholzer, Kathrin Maedler, Amin Ardestani
Ting Yuan, Sahar Rafizadeh, Zahra Azizi, Blaz Lupse, Kanaka Durga Devi Gorrepati, Sushil Awal, Jose Oberholzer, Kathrin Maedler, Amin Ardestani
View: Text | PDF
Research Article Cell biology Endocrinology

Proproliferative and antiapoptotic action of exogenously introduced YAP in pancreatic β cells

  • Text
  • PDF
Abstract

Loss of functional pancreatic β cells is a hallmark of both type 1 and 2 diabetes. Identifying the pathways that promote β cell proliferation and/or block β cell apoptosis is a potential strategy for diabetes therapy. The transcriptional coactivator Yes-associated protein (YAP), a major downstream effector of the Hippo signaling pathway, is a key regulator of organ size and tissue homeostasis by modulating cell proliferation and apoptosis. YAP is not expressed in mature primary human and mouse β cells. We aimed to identify whether reexpression of a constitutively active form of YAP promotes β cell proliferation/survival. Overexpression of YAP remarkably induced β cell proliferation in isolated human islets, while β cell function and functional identity genes were fully preserved. The transcription factor forkhead box M1 (FOXM1) was upregulated upon YAP overexpression and necessary for YAP-dependent β cell proliferation. YAP overexpression protected β cells from apoptosis triggered by multiple diabetic conditions. The small redox proteins thioredoxin-1 and thioredoxin-2 (Trx1/2) were upregulated by YAP; disruption of the Trx system revealed that Trx1/2 was required for the antiapoptotic action of YAP in insulin-producing β cells. Our data show the robust proproliferative and antiapoptotic function of YAP in pancreatic β cells. YAP reconstitution may represent a disease-modifying approach to restore a functional β cell mass in diabetes.

Authors

Ting Yuan, Sahar Rafizadeh, Zahra Azizi, Blaz Lupse, Kanaka Durga Devi Gorrepati, Sushil Awal, Jose Oberholzer, Kathrin Maedler, Amin Ardestani

×

Figure 2

YAP-induced human β cell proliferation is FOXM1 dependent.

Options: View larger image (or click on image) Download as PowerPoint
YAP-induced human β cell proliferation is FOXM1 dependent.
(A) FOXM1 gen...
(A) FOXM1 gene expression was analyzed by RT-PCR and levels normalized to cyclophilin and shown as change from control human islets infected with adenovirus expressing luciferase (Ad-Luc). Pooled data from 3 independent experiments from 3 different human islet donors (n = 3). (B and C) Western blots (B) and quantitative densitometry analysis (C) of FOXM1 protein level is shown. Western blots show results from 4 independent experiments from 4 different human islet donors (n = 4). (D–G) Human islets were infected with either control Ad-Luc or Ad-YAP and exposed to 10 μM FOXM1 inhibitor (thiostrepton; FOXM1i) for 2 days. β Cell proliferation was analyzed by double staining for Ki67 (D and E) or BrdU (F and G) (red) and insulin (green). (D and F) Pooled data from 4 independent experiments from 4 different human islet donors (n = 4). These 4 individual human islet data sets for Ad-Luc and Ad-YAP were also used for the quantification in Figure 1, A and C. Scale bar: 100 μm (applies to both E and G). Data are the mean ± SEM. *P < 0.05 for Ad-YAP compared with Ad-Luc–infected islets. **P < 0.05 for FOXM1i-treated Ad-YAP–infected compared with untreated Ad-YAP–infected islets. All 2-tailed Student’s t test except A (1-tailed).

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts